UNSPSC 51202701: Anti-thymocyte globulin

This classification denotes an immunosuppressant.

UNSPSC 51202701 Anti-thymocyte globulin, a Commodity code, shows material misalignment between its nominal scope and actual state and local procurement activity. Recent opportunities tagged to this code involve naloxone, first aid supplies, and generic pharmaceuticals—none of which are anti-thymocyte globulin, an immunosuppressive agent used in transplant and hematologic protocols. The source records describe emergency response and public health supply procurement across counties, cities, fire departments, and multi-state cooperative purchasing alliances, but the code's nominal product category does not match the work actually being solicited.

Activity appears concentrated in Florida (Seminole County), Texas (HHS Commission), and Minnesota (MMCAP cooperative), with an outlier city-level solicitation in Tampa. Recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems posted June 30, 2026 (due July 26, 2023—note date inconsistency in source); the City of Tampa's ITB for medical and first aid supplies posted March 25, 2026 with a response deadline of March 13, 2026 and an estimated contract value of $700,000.00; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products posted January 20, 2026 with responses due March 26, 2026. The Texas HHS Commission issued an RFI on April 3, 2026 regarding direct-to-manufacturer prescription programs, signaling exploratory procurement in therapeutic pharmacy infrastructure. The code appears to capture emergency medical and pharmaceutical supply procurement generally rather than the specific immunosuppressive product its name indicates, suggesting either systematic mis-tagging in state and local procurement systems or scope drift in how the code is applied.